Clinical practice that utilizes chronic opioid therapy has been recognized as one major cause of the opioid crisis. Among patients living with HIV, the risks associated with chronic opioid therapy may be complicated by factors such as co-occurring mental health diagnoses, substance use, and economic marginalization. Improving opioid prescribing practices in HIV clinics requires attention to these and other characteristics common to HIV care. In the context of a randomized controlled trial testing an intervention to improve opioid prescribing practices in HIV outpatient clinics, we interviewed physicians about their perspectives on chronic opioid therapy. Overwhelmingly, physicians voiced ambivalence about their own knowledge and comfort with prescription opioids. They raised concerns about the impact of opioid prescribing on patient-provider relationships and the increasing workload associated with prescribing and monitoring patients. In this report, we explore these concerns and propose several strategies for improving clinical care in which chronic opioid therapy is addressed.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose data [Internet]. National Center or Health Statistics; 2018. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. “Every ‘never’ I ever said came true”: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257–66.
Ciccarone D. Editorial for “US Heroin in Transition: Supply Changes, Fentanyl Adulteration and Consequences” IJDP special section. Int J Drug Policy. 2017;46:107–11.
Rummans TA, Burton MC, Dawson NL. How good intentions contributed to bad outcomes: the opioid crisis. Mayo Clin Proc. 2018;93(3):344–50.
Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD. Chronic pain in HIV-infected patients: relationship to depression, substance use, and mental health and pain treatment. Pain Med Malden Mass. 2015;16(10):1870–81.
Colasanti J, Lira MC, Cheng DM, Liebschutz JM, Tsui JI, Forman LS, et al. Chronic opioid therapy in HIV-infected patients: patients’ perspectives on risks. Monitoring and Guidelines: Clin Infect Dis; 2018.
Arentoft A, Byrd D, Monzones J, Coulehan K, Fuentes A, Rosario A, et al. Socioeconomic status and neuropsychological functioning: associations in an ethnically diverse HIV+ cohort. Clin Neuropsychol. 2015;29(2):232–54.
Sionean C, Le BC, Hageman K, Oster AM, Wejnert C, Hess KL, et al. HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection–National HIV Behavioral Surveillance System, 21 U.S. cities, 2010. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002. Morb Mortal Wkly Rep Surveill Summ. 2002;63(14):1–39.
Merlin JS, Walcott M, Kerns R, Bair MJ, Burgio KL, Turan JM. Pain self-management in HIV-infected individuals with chronic pain: a qualitative study. Pain Med Malden Mass. 2015;16(4):706–14.
Hansen L, Penko J, Guzman D, Bangsberg DR, Miaskowski C, Kushel MB. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symptom Manag. 2011;42(6):893–902.
Namisango E, Harding R, Atuhaire L, Ddungu H, Katabira E, Muwanika FR, et al. Pain among ambulatory HIV/AIDS patients: multicenter study of prevalence, intensity, associated factors, and effect. J Pain Off J Am Pain Soc. 2012;13(7):704–13.
Merlin JS, Zinski A, Norton WE, Ritchie CS, Saag MS, Mugavero MJ, et al. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2014;14(3):207–16.
Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(1):S91–7.
Tsui JI, Walley AY, Lira MC, Chaisson CE, Forman LS, Colasanti JA, et al. Opioid Prescribing Attitudes and Risk Mitigation Practices in Two HIV Clinics. Conference presentation presented at: Annual Meeting of the College on Problems of Drug Dependence; 2017; Montreal.
Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, et al. Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial. JAMA Intern Med. 2017.
Bauer SR, Katz MH. Going beyond guideline-concordant opioid therapy to improve patient safety. JAMA Intern Med. 2017;177(9):1272.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624–45.
Avorn J. Academic detailing: “Marketing” the best evidence to clinicians. JAMA. 2017;317(4):361–2.
Bruce RD, Merlin J, Lum PJ, Ahmed E, Alexander C, Corbett AH, et al. 2017 HIVMA of IDSA clinical practice guideline for the management of chronic pain in patients living with HIV. Clin Infect Dis. 2017;65(10):e1–37.
Katzman JG, Galloway K, Olivas C, McCoy-Stafford K, Duhigg D, Comerci G, et al. Expanding health care access through education: dissemination and implementation of the ECHO model. Mil Med. 2016;181(3):227–35.
Weinstein RS, Lopez AM, Joseph BA, Erps KA, Holcomb M, Barker GP, et al. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med. 2014;127(3):183–7.
Starrels JL, Peyser D, Haughton L, Fox A, Merlin JS, Arnsten JH, et al. When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: a qualitative study of HIV treatment providers. Subst Abuse. 2016;37(1):148–53.
This work was supported by the National Institutes of Health/National Institutes of Drug Abuse [R01DA037768 to J.H.S and C.d.R.]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.
Conflicts of interest
All authors declare that they have no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in this study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Carroll, J.J., Colasanti, J., Lira, M.C. et al. HIV Physicians and Chronic Opioid Therapy: It’s Time to Raise the Bar. AIDS Behav 23, 1057–1061 (2019). https://doi.org/10.1007/s10461-018-2356-2